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Abstract
Background:  The aim of the current study was to assess the reliability, validity and the
psychometric properties of the Greek translation of the Symptoms Rating Scale For Depression
and Anxiety. The scale consists of 42 items and permits the calculation of the scores of the Beck
Depression Inventory (BDI)-21, the BDI 13, the Melancholia Subscale, the Asthenia Subscale, the
Anxiety Subscale and the Mania Subscale
Methods: 29 depressed patients 30.48 ± 9.83 years old, and 120 normal controls 27.45 ± 10.85
years old entered the study. In 20 of them (8 patients and 12 controls) the instrument was re-
applied 1–2 days later. Translation and Back Translation was made. Clinical Diagnosis was reached
by consensus of two examiners with the use of the SCAN v.2.0 and the IPDE. CES-D and ZDRS
were used for cross-validation purposes. The Statistical Analysis included ANOVA, the Spearman
Correlation Coefficient, Principal Components Analysis and the calculation of Cronbach's alpha.
Results: The optimal cut-off points were: BDI-21: 14/15, BDI-13: 7/8, Melancholia: 8/9, Asthenia:
9/10, Anxiety: 10/11. Chronbach's alpha ranged between 0.86 and 0.92 for individual scales. Only
the Mania subscale had very low alpha (0.12). The test-retest reliability was excellent for all scales
with Spearman's Rho between 0.79 and 0.91.
Conclusions: The Greek translation of the SRSDA and the scales that consist it are both reliable
and valid and are suitable for clinical and research use with satisfactory properties. Their properties
are close to those reported in the international literature. However one should always have in mind
the limitations inherent in the use of self-report scales.
Background
The Symptoms Rating Scale for Depression and Anxiety
(SRSDA) [1] is based on the Beck Depression Inventory-I
(BDI-I) [2]. It has been enlarged to include 42 items (dou-
ble the number of BDI items and apart from the original
21 BDI items it contains several subscales [3], like the
Asthenia subscale [4], the Melancholia Inventory [1], the
Anxiety Inventory [1], and the Mania subscale [1]. Simul-
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taneously one can calculate the BDI-I-13 and BDI-I-21
scores. The composition of the SRSDA subscales is as
follows:
1. The 21-item Beck Depression Scale includes items 1 8,
11, 13, 14, 17, 18, 19, 20, 21, 22, 23, 25, 26, 27, 28, 29,
31, 32, 34, 41. These are scored: a = 0, b = 1, c = 2, d = 3.
2. The 13-item Beck Depression Scale includes items 1, 8,
11, 13, 14, 19, 20, 22, 28, 29, 32, 34 and 41. These are
scored a = 0, b = 1, c = 2, d = 3.
3. The 12-item Melancholia Subscaleincludes items 8, 11,
13, 17, 19, 20, 21, 22, 26, 29, 32 and 34. These are scored
a = 0, b = 1, c = 2, d = 3.
4. The 12-item Asthenia Subscale includes items 2, 5, 9,
17, 21, 24, 25, 27, 28, 29, 32 and 38. These are scored: a
= 0, b = 1, c = 2, d = 3.
5. The 14-item Anxiety Subscale includes items 3, 4, 5, 12,
15, 17, 21, 24, 25, 27, 33, 39, 40 and 42. These are scored:
a = 0, b = 1, c = 2, d = 3.
6. The 5-item Mania Subscale includes items which all are
graded 6, 10, 16, 30, 37. These are scored a = -1, b = 0, c =
0, d = +1
The SRSDA is not widely used, unlike the Zung Depres-
sion Rating Scale [5], the Beck Depression Inventory-I
(BDI-I) [2] or the CES-D [6]. In any case, all these scales
are supposed to be used as screening tools rather and not
as substitutes for an in-depth interview[7].
The aim of the current preliminary study was to assess the
reliability, validity and psychometric properties of the
Greek translation of the Symptom Rating Scale for
Depression and Anxiety (SRSDA) and its subscales.
Methods
Materials
Twenty-nine (29) depressed patients (16 males and 13
females) aged 30.48 ± 9.83 years (range 18–59) suffering
from Major Depressive disorder according to DSM-IV [8]
and depression according to ICD-10 criteria [9], and 120
normal controls (78 males and 42 females) aged 27.45 ±
10.85 years (range 18–55) entered the study. In 20 of
them (8 patients and 12 controls) the instrument was re-
applied 1–2 days later.
Patients were free of any medication for at least two weeks
and were physically healthy with normal clinical and lab-
oratory findings (Electroencephalogram, blood and bio-
chemical testing, thyroid function, test for pregnancy, B12
and folic acid).
Patients came from the inpatient and outpatient unit of
the 3rd Department of Psychiatry, Aristotle University of
Thessaloniki, University Hospital AHEPA, Thessaloniki,
Greece. They were consecutive cases and were chosen
because they fulfilled the above criteria.
Members of the hospital staff, and students composed the
control group. A clinical interview confirmed that they did
not suffer from any mental disorder and their prior history
was free from mental and thyroid disorder. They were free
of any medication for at least two weeks and were physi-
cally healthy.
All patients and controls provided written informed con-
sent before participating in the study.
Methods
Translation and Back Translation was made by two of
the authors; one of whom did the translation and the
other who did not know the original English text did the
back translation. The final translation was fixed by con-
sensus of both authors. For the original English text of the
scale see additional file 1. For the Greek translation see
additional file 2.
Clinical Diagnosis was reached by consensus of two
examiners. The Schedules for Clinical Assessment in Neu-
ropsychiatry (SCAN) version 2.0 [10,11] and the Interna-
tional Personality Disorders Examination (IPDE) [12-15]
were used. Both were applied by one of the authors (KNF)
who has official training in a World Health Organization
Training and Reference Centre. The IPDE did not contrib-
ute to the clinical diagnosis of depression, but was used in
the frame of a global and comprehensive assessment of
the patients. The second examiner performed an unstruc-
tured interview.
The Center for Epidemiological Studies-Depression (CES-
D) [6] and the Zung Depression Rating Scale (ZDRS) [16]
were applied to the subjects for purposes of cross-valida-
tion. The clinical diagnosis was used as the 'gold standard'
for the validation of the SRSDA. The use of a semi-struc-
tured interview strengthens this approach, which however
has certain inherent limitations.
Statistical Analysis
Analysis of Variance (ANOVA) [17], was used to search for
differences between groups.
Item Analysis [18] was performed, and the values of Cron-
bach's alpha (α) for SRSDA subscales were calculated.
The Spearman Rank Correlation Coefficient (rho) was cal-
culated to test the relationship between CES-D, ZDRS and
SRSDA subscales and also to assess the test-retest reliabil-BMC Psychiatry 2003, 3 http://www.biomedcentral.com/1471-244X/3/21
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ity. However, the calculation of correlation coefficients is
not a sufficient method to test reliability and reproducibil-
ity of a scale, because it is an index of correlation and not
an index of agreement [17,19,20]. The calculation of
means, standard deviations, averages and differences for
each SRSDA subscale score during the 1st (test) and 2nd
(retest) applications may provide an impression of the
stability of results over time.
Also, the means and the standard deviations of the differ-
ences concerning each SRSDA subscale between test and
retest were calculated and the plots of the test vs. retest
and difference vs. average value for each variable were cre-
ated. In fact it is not possible to use statistics to define
acceptable agreement [17]. However these plots may
assist decision. It is not possible to show all of these plots,
but the respected concerning the total BDI-I-21 score is
shown in figure 1. This method was used in previous stud-
ies concerning the validation of scientific methods [21].
Results
Patients and controls did not differ in age, however they
differed concerning all the SRSDA subscales (table 1).
The calculation of sensitivity (Sn) and specificity (Sp) at
various cut-off levels showed that the optimum cut-off
points were: BDI-21: 14/15 (Sn = 0.90, Sp = 0.87), BDI-
13: 7/8 (Sn = 0.93, Sp = 0.88), Melancholia: 8/9 (Sn =
0.87, Sp = 0.86), Asthenia: 9/10 (Sn = 0.87, Sp = 0.90),
Anxiety: 10/11 (Sn = 0.90, Sp = 0.87).
Chronbach's alpha ranged between 0.86 and 0.92 for
individual scales. More specifically: BDI-21: 0.92, BDI-13:
0.92, Melancholia: 0.89, Asthenia: 0.86, Anxiety: 0.88 and
Mania: 0.12 (table 1).
It is obvious that only the Mania subscale had very low
alpha (0.12), but the study sample was not appropriate
for the validation of this subscale.
Both the ZDRS and the CES-D correlated highly with all
SRSDA subscales. More specifically, the ZDRS Spearman
coefficients were: with BDI-21: 0.84, BDI-13: 0.84, Melan-
cholia: 0.82, Asthenia: 0.80, Anxiety: 0.82 and Mania:
0.37. The CES-D Spearman coefficients were: with BDI-
21: 0.83, BDI-13: 0.81, Melancholia: 0.80, Asthenia: 0.77,
Anxiety: 0.79 and Mania: 0.32. All the above correlations
were significant at p < 0.01 (table 2).
The test-retest reliability was excellent for all scales with
Spearman's R between 0.79 and 0.91. More specifically it
was BDI-21: 0.90, BDI-13: 0.84, Melancholia: 0.88, Asthe-
nia: 0.81, Anxiety: 0.79 and Mania: 0.91 (table 3).
The comparison between the values obtained during test
vs. those obtained during retest revealed no differences
Bivariate scatterplots of the first vs second measurement and of the difference between measurements vs average value of  measurements conceming the BDI-21 score Figure 1
Bivariate scatterplots of the first vs second measurement and of the difference between measurements vs average value of 
measurements conceming the BDI-21 score. The points of the test-retest plot are very close to the regression line (which is a 
dichotomous) and the points of the difference vs. average are within the 2 SD from the mean difference (the scatterplots are 
based on test-retest data from 20 subjects, however some points overlap)BMC Psychiatry 2003, 3 http://www.biomedcentral.com/1471-244X/3/21
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(tables 4 and 5). The values that come from the division
of the minimum and maximum difference to the standard
deviation of the difference (table 5) is desirable to be gen-
erally between ±2. It is seems that some minor problems
exist with melancholia and mania subscales The interpre-
tion of the data shown in table 5 suggests that all subscales
are reliable conceming test-retest. Figure 1 constitute a
graphical representation of these results conceming BDI-I-
21.
Discussion
The present study is a preliminary effort to obtain data
concerning the psychometric properties of the Greek
translation of the Symptom Rating Scale for Depression
and Anxiety (SRSDA) and its subscales. The fact that
results are only preliminary should be stressed out,
because there is a need for further study concerning the
properties of the scale in larger and more representative
samples.
The use of self-report scales is frequent in psychiatric
research. However, it is also well known that this kind of
scales heavily depend on the co-operation and reading
ability of the patient. It is also known that the theoretical
background of their development influences their per-
formance. On the other hand they save time for the clini-
cian. The SRSDA is a comprehensive self-rating scale for
depression both in community and clinical settings. The
literature concerning its transcultural reliability and valid-
ity is limited. The current study reports observations on
the reliability, the validity and the psychometric proper-
ties of the Greek translation of the SRSDA. The results sug-
gest that this translation is well suited for use in the Greek
population with high sensitivity and specificity, high test-
retest reliability and high internal consistency.
The reliability and validity of the SRSDA has been tested
in a limited number of studies and no translation of this
scale has been published. This is in contrast to the large lit-
erature concerning the Zung Depression Rating Scale
(ZDRS) [16,22-25] or the CES-D [6,26-30]. Of course
there is a large body of research concerning the BDI,
which is the backbone of the SRSDA.
Various translations of the BDI have been published and
this scale was proved to be psychometrically strong and
appropriate for use in Argentina [31], Mexico [32], Brazil
[33], Malaya [34], Germany [35], Egypt [36] and Saudi
Arabia [37], while a Greek version has been applied to
neurological patients [38].
The present study reports that the best cut-off point for the
BDI-13 is 7/8 and for the BDI-21 is 14/15. The literature
is vast especially for the BDI-21 and opinions vary. It is
reported that the best cut-off point for the BDI-21 is 13/14
[39], 21 [40], 18 [35], 13 [41], or 16 [42]. It seems that
depending on the population, different cut-off points may
be applicable.
When the BDI is used for the assessment of special popu-
lations, then the researcher should be very careful in the
interpretation of the results. There are data concerning the
use of the BDI in subjects with low education [43], post-
natal depression [44], adolescent depression [45], geriat-
ric patients [46,47], neurological patients [38],
rheumatoid arthritis patients [32], chronic fatigue syn-
drome [48], Parkinson's disease [49] and dialysis patients
[50].
Concerning the psychometric properties of the BDI, it
seems that a single cut-off point is not feasible [39]. There
are data suggesting that there is a 40% decline in BDI
scores over 8 weeks, a main effect that accounts for
approximately 10% of the variance. This may be due to
repeated measurement alone, not due to any intervention.
This change likely represents measurement error with this
instrument rather than any "real" change in depression
[51]. Shortcomings of the BDI are its high item difficulty,
lack of representative norms, and thus doubtful objectiv-
ity of interpretation, controversial factorial validity, insta-
Table 1: Means, standard deviations and Cronbach's alpha conceming the Beck Depression Inventory (BDI-I)-21, BDI-I-13, the 
Melancholia Subscale, the Asthenia Subscale, the Anxiety Subscale and the Mania Subscale in depressed patients and controls
controls N = 120 Depressed N = 29
Mean Std. Dev. Mean Std. Dev. F p-level alpha
Age 27.45 10.85 30.48 9.83 1.31 0.254
BDI-I-21 8.16 7.65 28.65 10.95 122.24 0.000 0.92
BDI-I-13 3.56 4.37 17.43 7.95 143.56 0.000 0.92
Melancholia Subscale 4.51 4.63 17.22 7.46 115.55 0.000 0.89
Asthenia Subscale 4.87 4.51 16.35 5.73 118.64 0.000 0.86
Anxiety Subscale 5.64 5.19 19.13 6.52 121.23 0.000 0.88
Mania Subscale -0.42 0.70 -0.09 0.29 6.61 0.011 0.12BMC Psychiatry 2003, 3 http://www.biomedcentral.com/1471-244X/3/21
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bility of scores over short time intervals (over the course
of 1 day), and poor discriminant validity against anxiety.
Advantages of the inventory are its high internal consist-
ency, high content validity, validity in differentiating
between depressed and nondepressed subjects, sensitivity
to change, and international propagation [52]. Generally
a two factor model solution is proposed for the BDI, but
only the first (general) factor seems to be stable [53]. It is
also reported that very low scorers on the BDI tend to
respond in a "fake-good" manner on the Minnesota
Multiphasic Personality Inventory (MMPI) validity scales.
This findings was interpreted as evidence of poor "low-
end specificity" for the BDI [54].
There is a great controversy concerning which kind of
scales (self-report or observer-rating) is best. Although
some authors favour the BDI over observer rating scales
[55], it seems that it has only moderate relationship to
observer rating scales like the MADRS and the HDRS [56-
60]. This may mean that different aspects of depression
are assessed by different instrument modalities, but also
may mean that there is a need for a comprehensive and
multimodal assessment of patients.
There is also a great debate concerning which one from
the self report scales is best. Research provides no consist-
ent data on the superiority of a specific scale over the oth-
ers. It is reported that the BDI is equal to CES-D [40,61]
there is a significant relationship between the BDI and the
MMPI-D scale [62]. The comparison between the BDI, the
Zung Self-Rating Depression Scale (SDS), and the Taylor
Manifest Anxiety Scale (TMAS) for specificity and validity
as measures of anxiety and depression and their relation-
ship to the Neuroticism scale of the Eysenck Personality
Inventory (EPI-N), suggest all four tests tap an emotional-
ity factor of stability-instability [63].
Review studies on various self-administered instruments
suggest that there is no significant difference among these
scales in terms of performance and overall sensitivity is
around 0.84 and specificity around 0.72 [64]. These
instruments are of particular value in primary care settings
because it is clear that primary care providers fail to diag-
nose and treat as many as 35% to 50% of patients with
depressive disorders [65,66]. Depression is one of the
most common psychiatric diagnoses in primary care pop-
ulations [67]; major depressive disorders can be diag-
nosed in 6% to 9% of such patients. Obstacles to the
appropriate recognition of depression include inadequate
provider knowledge of diagnostic criteria; competing
comorbid conditions and priorities among primary care
patients; time limitations in busy office settings; concern
about the implications of labelling; poor reimbursement
mechanisms; and uncertainty about the value, accuracy,
and efficiency of screening mechanisms for identifying
Table 2: Correlation between ZDRS, CES-D and SRSDA 
subscales. All correlations are significant at p < 0.001
ZDRS CES-D
BDI-I-21 0.84 0.83
BDI-I-13 0.84 0.81
Melancholia Subscale 0.82 0.80
Asthenia Subscale 0.80 0.77
Anxiety Subscale 0.82 0.79
Mania Subscale 0.37 0.32
Table 3: Spearman rho concerning test-retest results
Spearman Rho
BDI-I-21 0.95
BDI-I-13 0.89
Melancholia Subscale 0.95
Asthenia Subscale 0.85
Anxiety Subscale 0.80
Mania Subscale 0.92
Table 4: Correlation coefficients concerning the test retest 
reliability of individual BDI items and total scores for BDI-13 and 
BDI-21. Items marked with an asterisk constitute the BDI-13 
scale
SRDA item R
Item 1* 0.52
Item 8* 0.88
Item 11* 0.64
Item 13* 0.22
Item 14* 0.74
Item 17 0.37
Item 18 1.00
Item 19* 0.35
Item 20* 0.64
Item 21 0.36
Item 22* 0.48
Item 23 0.89
Item 25 0.58
Item 26 0.49
Item 27 0.64
Item 28* -0.05
Item 29* 0.78
Item 31 0.6
Item 32* 0.83
Item 34* 0.69
Item 41* 0.83
BDI-I-21 0.95
BDI-I-13 0.89BMC Psychiatry 2003, 3 http://www.biomedcentral.com/1471-244X/3/21
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patients with depression. Given that 50% to 60% of per-
sons seeking help for depression are treated exclusively in
the primary care setting, accurate detection in this setting
is important [68] and self-administered instruments may
help to ameliorate some of them.
On the other hand, it should be noted that the diagnosis
of depression is itself based on symptoms. A patient can-
not be truly asymptomatic and have major depressive dis-
order. Thus, these screening questionnaires are actually
being evaluated for their ability to detect unrecognized,
rather than true asymptomatic, depressive symptoms and
disease. They are also useful for the assessment of severity
but not for the diagnosis per se.
It should be also stressed that the current study offers only
preliminary data. The study sample is small; retest data are
available for only 18 subjects and the factor analysis
included both patients and controls. The complete valida-
tion demands the application of the scale in larger sam-
ples and more sophisticated methodology, including the
use of borderline severity samples.
Conclusions
The Greek translation of the SRSDA and its subscales is
both reliable and valid and is suitable for clinical and
research use with satisfactory properties. Its properties are
similar to those reported in the international literature.
However one should always have in mind the limitations
inherent in the use of self-report scales.
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Table 5: Means, standard deviations, minimum and maximum for all SRSDA subscales conceming their test, retest, average and 
difference between the two applications. The two columns to the right represent the division of the minimum and maximum difference 
to the standard deviation of the difference. It is desirable these values to be generally between ±2. It is obvious that some minor 
problems exist with melancholia and mania subscales
Valid N Mean Minimum Maximum Std. Dev. Lower deviance
in SDs
Upper deviance
in SDs
BDI-I-21
test 20 10.85 0.00 24.00 8.19
retest 20 10.80 0.00 27.00 9.50
average 20 10.83 0.50 23.50 8.65
difference 20 0.05 -7.00 8.00 3.89 -1.80 2.06
BDI-I-13
test 20 5.25 0.00 13.00 4.24
retest 20 4.85 0.00 13.00 5.20
average 20 5.05 0.00 11.50 4.55
difference 20 0.40 -4.00 5.00 2.72 -1.47 1.84
Melancholia subscale
test 20 6.30 0.00 16.00 4.78
retest 20 6.40 0.00 17.00 5.40
average 20 6.35 0.00 14.50 4.94
difference 20 -0.10 -6.00 4.00 2.53 -2.37 1.58
Asthenia subscale
test 20 6.05 0.00 12.00 4.11
retest 20 6.40 0.00 14.00 4.89
average 20 6.23 0.00 12.00 4.27
difference 20 -0.35 -5.00 4.00 2.94 -1.70 1.36
Anxiety subscale
test 20 6.75 0.00 17.00 5.54
retest 20 7.65 0.00 19.00 6.53
average 20 7.20 0.00 15.00 5.72
difference 20 -0.90 -8.00 5.00 3.99 -2.01 1.25
Mania subscale
test 20 -0.50 -2.00 0.00 0.69
retest 20 -0.55 -2.00 0.00 0.69
average 20 -0.53 -2.00 0.00 0.68
difference 20 0.05 0.00 1.00 0.22 0.00 4.55BMC Psychiatry 2003, 3 http://www.biomedcentral.com/1471-244X/3/21
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